Site Search
Professionals 673 results
Capabilities 88 results
Practice Area
Product Liability & Mass Torts
Major multinational companies trust Winston to defend their products and reputations in high-profile, high-stakes product liability and mass tort claims. Our Product Liability & Mass Torts Practice is one of the industry’s most seasoned, with a deep bench of experienced lawyers and a unique combination of extensive trial experience and expansive technical knowledge.
Practice Area
Derivatives & Structured Products
Winston represents swap dealers, major swap participants, financial intermediaries, hedge funds, national exchanges, and end-users in a broad array of derivative transactions ranging from highly structured transactions to more traditional trading or hedging transactions, and in regulatory and enforcement issues related to commodities and derivatives.
Practice Area
Brands across key sectors turn to Winston litigators to defend their reputations in advertising class actions, competitor disputes, and investigations. With litigators based in the U.S.’s busiest jurisdictions—including courts in California, Florida, Illinois, New York, and Texas—we have deep experience and prowess in handling some of the most high-profile and business-essential advertising cases in recent history. These disputes have involved false advertising; unfair competition, unfair business practices, and unjust enrichment; copyright, trade name, and service mark infringement; consumer-protection claims; and violations of the Lanham Act.
Experience 233 results
Experience
|February 4, 2026
A Winston & Strawn deal team led by Partners Justin Levy in New York and Paul Amiss in London advised Aeron Defense, a newly formed defense platform established by Ventus Industrial Partners in partnership with GenNx360 Capital Partners and Admiralty Partners, on its acquisition of defense contracting specialists General Tool Company and Magna Machine Company.
Experience
|February 2, 2026
A Winston & Strawn deal team led by Partners Justin Levy in New York and Paul Amiss in London advised Aeron Defense, a newly formed defense platform established by Ventus Industrial Partners in partnership with GenNx360 Capital Partners and Admiralty Partners, on its acquisition of defense contracting specialists General Tool Company and Magna Machine Company.
Experience
|January 22, 2026
Advised SQM on US$600M offering of subordinated capital notes due 2056 (Hybrid Bond Offering)
Winston & Strawn LLP advised longstanding client Sociedad Química y Minera de Chile S.A. (“SQM”) (NYSE: SQM) on its US$600 million offering of subordinated capital notes. The notes were offered in the United States pursuant to Rule 144A and outside the United States pursuant to Regulation S.The subordinated capital notes are due in 2056 and constitute SQM’s first international hybrid bond issuance, structured to be consistent with SQM’s recent UF 10 million (approximately US$ 430 million) Series S hybrid-subordinated bond issuance in the Chilean securities market. The notes bear an initial annual interest rate of 5.625% and are subject to reset on April 22, 2031 (the “First Reset Date”), and on every fifth anniversary thereafter, based on a spread over the 5-year U.S. Treasury bond rate, with interest rate step-ups on the fifth and twentieth anniversaries of the First Reset Date. The transaction closed on January 22, 2026.BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Santander US Capital Markets LLC, and Scotia Capital (USA) Inc. acted as initial purchasers of the notes.Link Capital Partners was financial advisor to SQM.SQM is a global company with a leading position in the lithium, iodine, and potassium nitrate markets. It develops and produces a diverse range of products for industries essential to human progress, including health, nutrition, renewable energy, and technology, driven by innovation and technological development.The Winston & Strawn team advising on the transaction included corporate partner Sey-Hyo Lee (New York) and foreign legal advisor Bruno M. Fiorino (New York). Partner Katherine Erbeznik (New York) advised on tax matters.
Insights & News 5,756 results
Webinar
|March 10, 2026
Private Fund Focus on Regulatory Trends, Compliance Practices, & SEC Initiatives
Join Winston & Strawn and the Alternative Investment Management Association (AIMA) for a workshop focused on private fund managers, exploring the regulatory trends and compliance practices in a continuously evolving regulatory environment. Partners Beth Kramer and Scott Naidech, and Five Bells Settlement Corp.’s Chief Legal Officer, Matthew Siano, will discuss current SEC initiatives and compliance practices utilized by private equity funds, hedge funds, and alternative investment fund managers relating to conflicts of interest, fees and expenses, performance marketing, annual review, and SEC areas of focus.
Webinar
|February 24, 2026
Venezuela in Transition: The Evolving Investment Landscape
Recent political developments in Venezuela are significantly impacting the country’s outlook, presenting novel challenges and opportunities for investment in the region.
Sponsorship
|February 22, 2026
Winston & Strawn Sponsors, Speaks at SFVegas 2026
Winston & Strawn is proud to sponsor the Structured Finance Association’s flagship SFVegas 2026 conference in Las Vegas. SFVegas is the premier global gathering for the structured finance community, drawing over 9,000 professionals from across the industry to explore the trends, challenges, and opportunities shaping securitization, lending, and capital formation.
Other Results 102 results
Law Glossary
What Are Interchangeable Biological Products?
A biological product is interchangeable if it is biosimilar to the reference product and is expected to produce the same clinical result as the reference product in any given patient. A biosimilar product that is deemed to be interchangeable by the FDA means the biosimilar product can be substituted for the reference product by a pharmacist without consulting the prescriber. The specific requirements for substitution vary by state.
Site Content
Location
Winston & Strawn’s New York office opened in 1989 and has since grown to become the firm’s second-largest location, with 225+ lawyers distributed across 16 practice areas. Based in the iconic MetLife Building above Grand Central Station in Midtown Manhattan, our New York lawyers represent 80+ Fortune 500 companies from the city’s business epicenter. Our New York attorneys are tenacious and insightful, and they reflect the rich tapestry of New York City, with lawyers from all backgrounds, experiences, and perspectives working closely to support each other's success and achieve their clients' goals. Several of our firmwide employee networks are chaired by New York attorneys. Our New York office’s welcoming and collaborative atmosphere can be seen through numerous office-wide events, including volunteer opportunities, gatherings to connect over food and drinks, wellness event pop-ups, and annual entry in the NYC Lawyers Basketball League. Creating a connected and supportive setting for attorneys and business professionals fosters camaraderie and encourages all of us to work harder for one another and our clients.